The global demand for Hospital Acquired Disease Testing Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period of 2022-2028.
Hospital-acquired disease testing involves the diagnosis of diseases contracted from microbial infections or toxins in a healthcare facility. The intensive care unit is the most common location in a hospital where anyone can contract an illness, increasing morbidity, mortality, and hospital costs. The most common diseases tested include surgical site infections, gastroenteritis, pneumonia, meningitis, and urinary tract infections. The primary cause of these diseases is unclean hands, medical instruments such as catheters, respiratory machines, and excessive or improper use of antibiotics. The testing for these diseases involves diagnosis by sight and symptoms alone and can appear within 48 hours of admission, three days after discharge, or 30 days after an operation.
Market Dynamics
Lack of poor hygiene and the emergence of drug-resistant organisms in healthcare facilities will be the vital stimulating agents for this market's growth. Increasing the geriatric population and inflating morbidity rates among patients undergoing treatment for chronic diseases in a healthcare facility will boost this market's growth. Technological advancements in the healthcare industry and novel diagnostic techniques and tools will benefit this market's growth. Better surveillance cultures to detect unseen pathogens in colonized patients and prevent transmission of infections will be a market booster. The lack of budget, skilled labor and stringent government regulations will be a few hindrances not favorable to market growth.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each segment in the global market of hospital acquired disease testing.
Market Segmentation
This section of the hospital acquired disease testing market report provides detailed data on the segments by analyzing them geographically, thereby assisting the strategist in identifying the target demographics for the respective product or service.
By Test Type
- Urinary Tract Infection
- Surgical Site Infection
- Pneumonia Stents
- Blood Stream Infection
- Methicillin-resistant Staphylococcus Aureus
By End User
- Hospitals and Intensive Care Units (ICUS)
- Ambulatory Surgical and Diagnostic Centers
- Nursing Homes and Maternity Centers
Regional Analysis
This section covers regional segmentation which accentuates on current and future demand for Hospital Acquired Disease Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Hospital Acquired Disease Testing Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the hospital acquired disease testing market include Abbott Laboratories,Diatherix Laboratories, LLC,bioMérieux S.A.,Life Technologies Corporation,Cantel Medical Corp.,Meridian Bioscience, Inc.,QIAGEN GmbH,Nordion Inc.,Roche Holding AG,Becton, Dickinson and Company. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . HOSPITAL ACQUIRED DISEASE TESTING – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 By Test Type
3.7.2 By End User
3.7.3 By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis
6 . GLOBAL HOSPITAL ACQUIRED DISEASE TESTING MARKET ANALYSIS BY TEST TYPE
6.1 Overview by Test Type
6.2 Historical and Forecast Data
6.3 Analysis by Test Type
6.4 Urinary Tract Infection Market by Regions
6.6 Surgical Site Infection Market by Regions
6.5 Pneumonia Stents Market by Regions
6.7 Blood Stream Infection Market by Regions
6.8 Methicillin-resistant Staphylococcus Aureus Market by Regions
7 . GLOBAL HOSPITAL ACQUIRED DISEASE TESTING MARKET ANALYSIS BY END USER
7.1 Overview by End User
7.2 Historical and Forecast Data
7.3 Analysis by End User
7.4 Hospitals and Intensive Care Units (ICUS) Market by Regions
7.5 Ambulatory Surgical and Diagnostic Centers Market by Regions
7.6 Nursing Homes and Maternity Centers Market by Regions
8 . GLOBAL HOSPITAL ACQUIRED DISEASE TESTING MARKET ANALYSIS BY GEOGRAPHY
8.1. Regional Outlook
8.2. Introduction
8.3. North America
8.3.1. Overview, Historic and Forecast Data
8.3.2. North America By Segment
8.3.3. North America By Country
8.3.4. United State
8.3.5. Canada
8.3.6. Mexico
8.4. Europe
8.4.1. Overview, Historic and Forecast Data
8.4.2. Europe by Segment
8.4.3. Europe by Country
8.4.4. United Kingdom
8.4.5. France
8.4.6. Germany
8.4.7. Italy
8.4.8. Russia
8.4.9. Rest Of Europe
8.5. Asia Pacific
8.5.1. Overview, Historic and Forecast Data
8.5.2. Asia Pacific by Segment
8.5.3. Asia Pacific by Country
8.5.4. China
8.5.5. India
8.5.6. Japan
8.5.7. South Korea
8.5.8. Australia
8.5.9. Rest Of Asia Pacific
8.6. Latin America
8.6.1. Overview, Historic and Forecast Data
8.6.2. Latin America by Segment
8.6.3. Latin America by Country
8.6.4. Brazil
8.6.5. Argentina
8.6.6. Peru
8.6.7. Chile
8.6.8. Rest of Latin America
8.7. Middle East & Africa
8.7.1. Overview, Historic and Forecast Data
8.7.2. Middle East & Africa by Segment
8.7.3. Middle East & Africa by Country
8.7.4. Saudi Arabia
8.7.5. UAE
8.7.6. Israel
8.7.7. South Africa
8.7.8. Rest Of Middle East And Africa
9 . COMPETITIVE LANDSCAPE OF THE HOSPITAL ACQUIRED DISEASE TESTING COMPANIES
9.1. Hospital Acquired Disease Testing Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments
10 . COMPANY PROFILES OF HOSPITAL ACQUIRED DISEASE TESTING INDUSTRY
10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Abbott Laboratories
10.3.1. Company Overview
10.3.2. Financials
10.3.3. Products
10.3.4. Recent Developments
10.4. Diatherix Laboratories, LLC
10.4.1. Company Overview
10.4.2. Financials
10.4.3. Products
10.4.4. Recent Developments
10.5. bioMérieux S.A.
10.5.1. Company Overview
10.5.2. Financials
10.5.3. Products
10.5.4. Recent Developments
10.6. Life Technologies Corporation
10.6.1. Company Overview
10.6.2. Financials
10.6.3. Products
10.6.4. Recent Developments
10.7. Cantel Medical Corp.
10.7.1. Company Overview
10.7.2. Financials
10.7.3. Products
10.7.4. Recent Developments
10.8. Meridian Bioscience, Inc.
10.8.1. Company Overview
10.8.2. Financials
10.8.3. Products
10.8.4. Recent Developments
10.9. QIAGEN GmbH
10.9.1. Company Overview
10.9.2. Financials
10.9.3. Products
10.9.4. Recent Developments
10.10. Nordion Inc.
10.10.1. Company Overview
10.10.2. Financials
10.10.3. Products
10.10.4. Recent Developments
10.11. Roche Holding AG
10.11.1. Company Overview
10.11.2. Financials
10.11.3. Products
10.11.4. Recent Developments
10.12. Becton
10.12.1. Company Overview
10.12.2. Financials
10.12.3. Products
10.12.4. Recent Developments
10.13. Dickinson and Company
10.13.1. Company Overview
10.13.2. Financials
10.13.3. Products
10.13.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- COVID-19 Impact Analysis by Production, Import, Export and Demand
- Pre V/S Post COVID-19
- Estimated Impact Of The Coronavirus (Covid-19) Epidemic
- COVID-19: Micro and Macro Factor Analysis
- Analysis by Test Type (USD MN)
- Urinary Tract Infection Market by Geography (USD MN)
- Surgical Site Infection Market by Geography (USD MN)
- Pneumonia Stents Market by Geography (USD MN)
- Blood Stream Infection Market by Geography (USD MN)
- Methicillin-resistant Staphylococcus Aureus Market by Geography (USD MN)
- Analysis Market by End User (USD MN)
- Hospitals and Intensive Care Units (ICUS) Market by Geography (USD MN)
- Ambulatory Surgical and Diagnostic Centers Market by Geography (USD MN)
- Nursing Homes and Maternity Centers Market by Geography (USD MN)
- Global Hospital Acquired Disease Testing Market by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisiton
LIST OF FIGURES
- Research Scope of Hospital Acquired Disease Testing Report
- Market Research Process
- Market Research Methodology
- Global Hospital Acquired Disease Testing Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Test Type
- Market Attractiveness Analysis by End User
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Test Type (USD MN)
- Urinary Tract Infection Market by Geography (USD MN)
- Surgical Site Infection Market by Geography (USD MN)
- Pneumonia Stents Market by Geography (USD MN)
- Blood Stream Infection Market by Geography (USD MN)
- Methicillin-resistant Staphylococcus Aureus Market by Geography (USD MN)
- Global Market Analysis by End User (USD MN)
- Hospitals and Intensive Care Units (ICUS) Market by Geography (USD MN)
- Ambulatory Surgical and Diagnostic Centers Market by Geography (USD MN)
- Nursing Homes and Maternity Centers Market by Geography (USD MN)
- Global Market by Revenue
- North America Market by Revenue
- Europe Market by Revenue
- Asia Pacific Market by Revenue
- Latin America Market by Revenue
- Middle East & Africa Market by Revenue
- Recent Development in Industry
- Company Market Share Analysis
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.